Thus, whether serum, plasma or platelet 5-HT, or the other platelet biomarkers identified here, all of which are available in easily collected peripheral blood, identify living individuals at risk for SIDS requires focused studies in high risk populations or large, long-term, prospective population studies. This evidence concerns the gene HTR5A and sudden infant death syndrome.